Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Allurion Technologies Inc. (ALUR)
USD4.72
-0.79 (-14.27%)
US OTC Healthcare Medical - Devices
Address
11 Huron Drive 1760
Natick, MA, US
Natick, MA, US
CEO
Shantanu K. Gaur
Website
allurion.com
IPO
2021-03-29
CIK 1964979 ISIN US02008G2012
Description
Allurion Technologies Inc. is dedicated to combating obesity by offering a comprehensive weight management ecosystem designed for individuals with excess weight. At the core of its solution is the Allurion Program, featuring the innovative Allurion Balloon – a novel, non-surgical, swallowable intragastric device engineered to promote significant weight loss. This program is further enhanced by the Allurion Virtual Care Suite, which provides sophisticated AI-powered remote patient monitoring, a specialized behavior modification curriculum, encrypted messaging capabilities, and virtual telehealth consultations. The firm's main operational base is located in Natick, Massachusetts.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD4.72
-0.79 (-14.27%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
4.6K
Beta
-0.17
Float Shares
7.43M
Free Float %
98.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -10.42% | +13.47% | +6.38% | -21.20% | -39.21% | -30.81% | -72.19% | -99.67% | -99.65% | -99.65% | -99.65% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (2 ratings, all time)
Buy
Price Targets & DCF
Current price
4.72
Low
3.00
-36.4%
Consensus
3.00
-36.4%
Median
3.00
-36.4%
High
3.00
-36.4%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 2 |
3.00
-36.4%
|
| Last Year | 2 |
3.00
-36.4%
|
| All Time | 4 |
3.38
-28.3%
|
Quality scores
Altman Z-Score
-36.40
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%-52.6% Q1'26: -47.2% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%+67.3% ★ Q1'26: -48.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-233.7% Q1'26: -109.3% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-188.3% Q1'26: +0.0% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+235.7% Q1'26: +121.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-1.05× Q1'26: -1.97× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
53.47M
est: 48.78M (+9.6%)
|
32.11M
est: 32.30M (-0.6%)
|
15.23M
est: 14.81M (+2.8%)
|
15.06M
14.68M – 15.45M
+1.7% YoY
|
23.89M
23.28M – 24.50M
+58.6% YoY
|
213.00M
207.54M – 218.46M
+791.7% YoY
|
| EBITDA |
-69.03M
est: -13.68M (-404.5%)
|
-22.17M
est: -21.98M (-0.9%)
|
-27.70M
est: -10.08M (-174.8%)
|
-10.25M
-10.51M – -9.99M
-1.7% YoY
|
-16.26M
-16.67M – -15.84M
-58.6% YoY
|
-144.95M
-148.67M – -141.23M
-791.7% YoY
|
| EBIT |
-69.78M
est: -14.30M (-387.8%)
|
-23.17M
est: -22.39M (-3.5%)
|
-28.68M
est: -10.27M (-179.4%)
|
-10.44M
-10.71M – -10.17M
-1.7% YoY
|
-16.56M
-16.98M – -16.14M
-58.6% YoY
|
-147.66M
-151.44M – -143.87M
-791.7% YoY
|
| Net Income |
-80.61M
|
-26.15M
est: -96.38M (+72.9%)
|
-28.76M
est: -22.00M (-30.7%)
|
-6.90M
-7.13M – -6.67M
+68.6% YoY
|
-9.38M
-9.69M – -9.06M
-35.9% YoY
|
43.38M
41.94M – 44.83M
+562.7% YoY
|
| SGA |
92.88M
est: 62.38M (+48.9%)
|
54.33M
est: 48.48M (+12.1%)
|
32.16M
est: 22.23M (+44.7%)
|
22.61M
22.03M – 23.19M
+1.7% YoY
|
35.86M
34.94M – 36.78M
+58.6% YoY
|
319.73M
311.53M – 327.92M
+791.7% YoY
|
| EPS |
-57.83
|
-11.64
est: -10.86 (-7.1%)
|
-3.81
est: -2.94 (-29.7%)
|
-0.91
-0.95 – -0.88
+68.9% YoY
|
-1.24
-1.28 – -1.20
-35.9% YoY
|
5.75
5.56 – 5.94
+562.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-30.63M
OE per share TTM
-4.41
Owner's Yield
-57.99%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
10.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
27
Total invested
8.20M
Insider transactions (90d)
0
Beneficial owners (>5%)
5
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Armistice Capital, LLC | 8.08M | 12.60% | — | 8.08M | — | 8.08M | IA, OO | Delaware | 2024-08-09 | ↗ |
| 2 | Steven Boyd | 8.08M | 12.60% | — | 8.08M | — | 8.08M | HC, IN | Delaware | 2024-08-09 | ↗ |
| 3 | RTW Investments, LP | 3.46M | 7.40% | — | 3.46M | — | 10.00 | IA, PN | Delaware | 2023-08-11 | ↗ |
| 4 | Roderick Wong, M.D. | 3.46M | 7.40% | — | 3.46M | — | 10.00 | HC, IN | United States of America | 2023-08-11 | ↗ |
| 5 | 2. | 10.00 | 5.10% | — | 2.56M | — | — | HC, IN | Delaware | 2023-12-26 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2025 Q4
Investors holding
27
+7 vs prev Q
New positions
9
Closed positions
2
Increased
15
Reduced
3
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | EMPERY ASSET MANAGEMENT, LP | 59.9K +59.9K (+100.0%) | 73.65M +73.7M (+100.0%) | 0.08% +0.077 pp | 0.06% +0.065 pp | USD1.23 +0.0% | 1 qtrs NEW |
| 2 | — | 59.9K +59.9K (+100.0%) | 73.65M +73.7M (+100.0%) | 0.08% +0.077 pp | 0.05% +0.048 pp | USD1.23 +0.0% | 1 qtrs NEW |
| 3 | RTW INVESTMENTS, LP | 5.89M +3.3M (+131.7%) | 7.25M +2.0M (+39.0%) | 7.59% +4.107 pp | 0.07% +0.008 pp | USD1.89 -34.9% | 4 qtrs — |
| 4 | LUNT CAPITAL MANAGEMENT, INC. | 166.7K +166.7K (+100.0%) | 205.0K +205.0K (+100.0%) | 0.21% +0.215 pp | 0.08% +0.077 pp | USD1.23 +0.0% | 1 qtrs NEW |
| 5 | VANGUARD GROUP INC | 88.7K +32.5K (+57.8%) | 109.0K -6.1K (-5.3%) | 0.11% +0.037 pp | 0.00% +0.000 pp | USD2.40 -48.8% | 4 qtrs — |
| 6 | HUDSON BAY CAPITAL MANAGEMENT LP | 59.9K +59.9K (+100.0%) | 87.1K +87.1K (+100.0%) | 0.08% +0.077 pp | 0.00% +0.000 pp | USD1.23 +0.0% | 1 qtrs NEW |
| 7 | ARMISTICE CAPITAL, LLC | 59.9K +59.9K (+100.0%) | 73.7K +73.7K (+100.0%) | 0.08% +0.077 pp | 0.00% +0.001 pp | USD1.23 +0.0% | 1 qtrs NEW |
| 8 | HEIGHTS CAPITAL MANAGEMENT, INC | 59.9K +59.9K (+100.0%) | 73.7K +73.7K (+100.0%) | 0.08% +0.077 pp | 0.03% +0.026 pp | USD1.23 +0.0% | 1 qtrs NEW |
| 9 | UNISPHERE ESTABLISHMENT | 49.7K +— (+0.0%) | 61.1K -40.8K (-40.0%) | 0.06% -0.004 pp | 0.00% 0.000 pp | USD3.21 -61.7% | 4 qtrs — |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 40.3K +709.0 (+1.8%) | 49.6K -31.6K (-38.9%) | 0.05% -0.002 pp | 0.00% +0.000 pp | USD3.17 -61.2% | 4 qtrs — |
| 11 | UBS GROUP AG | 29.9K -29.3K (-49.5%) | 36.7K -84.5K (-69.7%) | 0.04% -0.043 pp | 0.00% +0.000 pp | USD3.21 -61.7% | 4 qtrs — |
| 12 | STATE STREET CORP | 26.1K +11.3K (+76.2%) | 32.1K +1.7K (+5.7%) | 0.03% +0.013 pp | 0.00% +0.000 pp | USD1.91 -35.6% | 3 qtrs — |
| 13 | BLACKROCK, INC. | 18.9K +— (+0.0%) | 23.2K -15.5K (-40.0%) | 0.02% -0.002 pp | 0.00% +0.000 pp | USD3.21 -61.7% | 4 qtrs — |
| 14 | NORTHERN TRUST CORP | 14.8K +14.8K (+100.0%) | 18.2K +18.2K (+100.0%) | 0.02% +0.019 pp | 0.00% +0.000 pp | USD1.23 +0.0% | 1 qtrs NEW |
| 15 | XTX TOPCO LTD | 12.6K +351.0 (+2.9%) | 15.5K -9.6K (-38.3%) | 0.02% -0.001 pp | 0.00% -0.001 pp | USD2.93 -58.0% | 4 qtrs — |
| 16 | CENTERPOINT ADVISORS, LLC | 6.3K +— (+0.0%) | 8.0K -5.0K (-38.5%) | 0.01% -0.001 pp | 0.00% -0.002 pp | USD2.84 -56.7% | 4 qtrs — |
| 17 | DV EQUITIES, LLC | 6.00 +6.0 (+100.0%) | 7.0K +7.0K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.17 +5.1% | 1 qtrs NEW |
| 18 | LRI INVESTMENTS, LLC | 5.0K +— (+0.0%) | 6.2K -4.1K (-40.0%) | 0.01% 0.000 pp | 0.00% 0.000 pp | USD2.43 -49.4% | 3 qtrs — |
| 19 | TORONTO DOMINION BANK | 162.0K +162.0K (+100.0%) | 3.2K +3.2K (+100.0%) | 0.21% +0.209 pp | 0.00% +0.000 pp | USD1.23 +0.0% | 1 qtrs NEW |
| 20 | ADVISOR GROUP HOLDINGS, INC. | 504.00 -286.0 (-36.2%) | 619.00 -1.1K (-63.9%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD3.21 -61.7% | 4 qtrs — |
| 21 | GROUP ONE TRADING, L.P. | 199.00 +— (+0.0%) | 245.00 -163.0 (-40.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.21 -61.7% | 4 qtrs — |
| 22 | LIMESTONE INVESTMENT ADVISORS LP | 11.0K +— (+0.0%) | 168.00 -128.0 (-43.2%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD2.05 -40.0% | 2 qtrs — |
| 23 | BANK OF AMERICA CORP /DE/ | 56.00 +16.0 (+40.0%) | 69.00 -13.0 (-15.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.54 -51.6% | 4 qtrs — |
| 24 | SBI SECURITIES CO., LTD. | 10.00 -3.0 (-23.1%) | 12.00 -15.0 (-55.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.90 -35.3% | 5 qtrs — |
| 25 | JPMORGAN CHASE & CO | 4.00 +— (+0.0%) | 5.00 -3.0 (-37.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 -59.0% | 4 qtrs — |
| 26 | SIGNATUREFD, LLC | 3.00 +— (+0.0%) | 4.00 -2.0 (-33.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 -59.0% | 4 qtrs — |
| 27 | HARBOUR INVESTMENTS, INC. | 2.00 +— (+0.0%) | 2.00 -2.0 (-50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 -59.0% | 4 qtrs — |
| 28 | TOWER RESEARCH CAPITAL LLC (TRC) | — -1.1K (-100.0%) | — -2.2K (-100.0%) | 0.00% -0.001 pp | 0.00% 0.000 pp | USD— | 4 qtrs SOLD |
| 29 | ALLWORTH FINANCIAL LP | — -11.0 (-100.0%) | — -23.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
2.40
Bullish
Ratio by volume
3.00
Bullish
Buys
12
Sells
5
Shares acquired
5.21M
Shares disposed
6.4K
Cash buys
—
Cash sales
2.00
Net activity
+5,201,903
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Gibbons Brendan M. | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-12-31 | Buch Ojas | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-12-04 | Davin Michael R | Director | S-Sale | D | Common Stock | 1,606 | 1.58 | 2.5K | 0 | I | ↗ |
| 2025-12-03 | Davin Michael R | Director | S-Sale | D | Common Stock | 1,606 | 1.48 | 2.4K | 1,606 | I | ↗ |
| 2025-11-26 | Davin Michael R | Director | G-Gift | A | Common Stock | 2,608 | 0.00 | — | 3,212 | I | ↗ |
| 2025-11-12 | RTW INVESTMENTS, LP | Director / 10% Owner | A-Award | A | Warrant (Right to Buy) | 991,544 | 1.67 | 1.66M | 991,544 | I | ↗ |
| 2025-11-05 | RTW INVESTMENTS, LP | Director / 10% Owner | C-Conversion | A | Common Stock, $0.0001 par value per share | 822,722 | 3.35 | 2.76M | 2,147,254 | I | ↗ |
| 2025-10-03 | Davin Michael R | Director | G-Gift | A | Common Stock | 604 | 0.00 | — | 604 | I | ↗ |
| 2025-05-19 | Gaur Shantanu | Director / Officer | P-Purchase | A | Common Stock | 8,000 | 3.06 | 24.5K | 16,000 | D | ↗ |
| 2025-04-16 | RTW INVESTMENTS, LP | Director / 10% Owner | C-Conversion | A | Common Stock, $0.0001 par value per share | 822,722 | 3.35 | 2.76M | 1,324,532 | I | ↗ |
| 2025-03-28 | Gaur Shantanu | Director / Officer | P-Purchase | A | Common Stock | 8,000 | 3.35 | 26.8K | 8,000 | D | ↗ |
| 2025-01-14 | RTW INVESTMENTS, LP | 10% Owner | — | — | Common Stock, $0.0001 par value per share | 0 | 0.00 | — | 26,551 | I | ↗ |
| 2024-12-30 | Richey Robert Jason | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-12-16 | RTW INVESTMENTS, LP | 10% Owner | — | — | Warrants (Right to Buy) | 12,369 | 30.00 | 371.1K | 0 | I | ↗ |
| 2024-11-08 | Johns Keith B II | Director | A-Award | A | Common Stock | 326,086 | 0.00 | — | 326,086 | D | ↗ |
| 2024-11-08 | Gibbons Brendan M. | Officer | A-Award | A | Common Stock | 306,749 | 0.00 | — | 306,749 | D | ↗ |
| 2024-11-08 | Buch Ojas | Officer | A-Award | A | Common Stock | 306,749 | 0.00 | — | 306,749 | D | ↗ |
| 2024-09-02 | Johns Keith B II | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-05-03 | Gaur Shantanu | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 1,428,571 | 2.30 | 3.29M | 1,428,571 | — | ↗ |
| 2024-02-08 | Gibbons Brendan M. | Officer | A-Award | A | Stock Option (Right to Buy) | 253,807 | 2.96 | 751.3K | 253,807 | — | ↗ |
| 2023-10-23 | LEWIN NICHOLAS SHERIDAN | Director | A-Award | A | Common Stock | 45,235 | 0.00 | — | 45,235 | — | ↗ |
| 2023-08-01 | LEWIN NICHOLAS SHERIDAN | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-214.0K
Shares Outstanding
7.54M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ojas A. Buch | Chief Operating Officer | 457.0K | male |
| Brendan Michael Gibbons | Chief Legal & People Officer and Secretary | 457.0K | male |
| Shantanu K. Gaur | Co-Founder, Chief Executive Officer, President, Principal Financial & Accounting Officer and Director | 319.2K | — |
| Matt Wright | Vice President of People | — | male |
| Laurent Laffineur | Vice President of International Sales & Marketing | — | male |
| Ram Chuttani | MD & Founding Partner | — | — |
| Samuel G. Levy | Co-Founder | — | — |
| Alexandra van der Stap | Vice President of Global Marketing | — | female |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ALUR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
